09 Apr 2015
The U.S. Food and Drug Administration has accepted a resubmitted application for Novo Nordisk’s key insulin drug, Tresiba, based on interim analysis data from a clinical trial.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024